A bill to amend the Controlled Substances Act to list fentanyl-related substances as schedule I controlled substances.

Bill 119 s 165, also known as the Fentanyl-related Substances Act, is a proposed amendment to the Controlled Substances Act. The purpose of this bill is to classify fentanyl-related substances as Schedule I controlled substances.

Fentanyl is a powerful synthetic opioid that is responsible for a significant portion of opioid-related deaths in the United States. Fentanyl-related substances are chemical compounds that are similar in structure and effects to fentanyl. These substances are often created in clandestine laboratories and sold on the black market, contributing to the opioid crisis.

By listing fentanyl-related substances as Schedule I controlled substances, this bill aims to increase penalties for the manufacture, distribution, and possession of these dangerous drugs. Schedule I controlled substances are considered to have a high potential for abuse and no accepted medical use, making them illegal to possess or distribute. Supporters of the bill argue that classifying fentanyl-related substances as Schedule I controlled substances will help to curb the opioid epidemic by cracking down on the production and distribution of these deadly drugs. Critics, however, raise concerns about the potential impact on individuals who may inadvertently come into contact with fentanyl-related substances or who use them for legitimate medical purposes. Overall, Bill 119 s 165 represents a significant effort to address the growing threat of fentanyl-related substances and their role in the opioid crisis. The bill is currently under consideration in Congress, where lawmakers will debate its potential impact and implications for public health and safety.